Article

Minocycline shows promise as safe neuroprotective agent

Tel Hashomer, Israel-Results of preclinical studies suggest that minocycline has potential utility as a neuroprotective agent in the management of optic nerve diseases, said Hani Levkovitch-Verbin, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.